Last edition
News about "Sen-Jam Pharmaceutical "
Sen-Jam Pharma Completes Enrollment for Phase 2 URIs or COVID
Sen-Jam Pharmaceutical has completed participant enrollment for the clinical trial of its innovative therapeutic, SJP-002C in partnership with Duke University.
Sen-Jam Pharmaceutical | 25/06/2024 | By Aishwarya | 139
Sen-Jam Pharmaceutical and KVK-Tech to Provide CMC for Anti-Inflammatory Injectable
Sen-Jam Pharmaceutical has entered a third strategic collaboration with KVK-Tech.
Sen-Jam Pharmaceutical | 11/04/2024 | By Aishwarya | 291
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy